---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-312560"
form_type: "8-K"
ticker: "ARTV"
cik: "0001817241"
company_name: "Artiva Biotherapeutics, Inc."
filed_at: "2026-07-22T21:15:36+00:00"
generated_at: "2026-07-22T21:18:09.258539+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Artiva Biotherapeutics sets 2026 annual meeting for Sept 8; stockholder proposal deadline Aug 1

## Summary
- Annual meeting scheduled for September 8, 2026.
- Stockholder proposals and nominations due by close of business on August 1, 2026.
- Deadline applies to both business brought before meeting and director nominations.
- Rule 14a-8 proposals for proxy inclusion also due by August 1, 2026.
- Notices must be sent to Artiva's principal executive offices in San Diego.

## SEC filing metadata
- accession: 0001193125-26-312560
- form_type: 8-K
- ticker: ARTV
- cik: 0001817241
- company_name: Artiva Biotherapeutics, Inc.
- filed_at: 2026-07-22T21:15:36+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1817241/000119312526312560/0001193125-26-312560-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1817241/000119312526312560/artv-20260722.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-312560
- JSON: https://secwatch.observer/filing/0001193125-26-312560.json
- Plain text: https://secwatch.observer/filing/0001193125-26-312560.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.